SecBot SecBot

HIT

Health In Tech, Inc.
Nasdaq· Insurance Agents, Brokers & Service· CIK 0002019505 Traditional Finance
$0.5359 −0.03 (−4.64%)
Oct 26 4:00 PM ET · prev $0.5620
Market cap
$37.6M
Nano cap
Consensus
Buy
83% Buy or better · 6 analysts
Median target
$4.00
+646% · range $1.25–4.10
Next earnings
Nov 16
in 21 days · EPS est. −$0.04
1 year
−80.4%
from $2.73 · Oct 27
30 days
−39.2%
from $0.8810
52-week range
$0.5359–2.94
at the low
Avg volume 20D
422.0K
Sep 30 spike 6.16M
Short interest
408.6K
≈0.6% of shares · −33.5%
Days to cover
1.0
at average volume
Insider net
−$39.8K
0 buyers · 2 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 9 reports · 90 days
Balance 6 bearish · 0 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 8/9 ·Next Earnings date, Nov 16, 2026
Strongest BEARISH Health In Tech received two Nasdaq deficiency notices: (1) failure to comply with independent director and…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $39.8K.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    5 of 6 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.013 → −$0.045 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersCOVERING

    Short interest −33.5% to 408.6K shares. 1.0 days to cover, ≈0.6% of shares.

  • TrendDOWNTREND

    36% below its 50-day average. New closing low $0.5359 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCDOUBLED176,911$178.7K
VANGUARD FIDUCIARY TRUST COADD130,482$131.8K
NORTHERN TRUST CORPADD57,659$58.2K
UBS Group AGTRIM5,223$5.3K
MORGAN STANLEYNEAR_EXIT962$972.00
NORTHERN TRUST CORPTRIM36,150$52.4K
UBS Group AGNEAR_EXIT8,203$11.9K
VANGUARD GROUP INCADD640,043$1.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

6 analysts
Buy 83% rate it Buy or better
Strong Buy1Buy4Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +646%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Aug 14, 2026Maxim Group
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$39.8K
sold · 2 insiders
DateInsiderTypeValue
Oct 20, 2026
Shrestha Sanjay K
Chief Executive Officer
AWARD2,000,000 sh
Oct 20, 2026
Shrestha Sanjay K
Chief Executive Officer
AWARD1,500,000 sh
Oct 20, 2026
Shrestha Sanjay K
Chief Executive Officer
AWARD500,000 sh
Oct 16, 2026
Hasan Zain Syed
Chief Growth Officer
SELL$2.1K
Oct 15, 2026
Qian LinLin
Chief Executive Officer
TAX W/H$29.9K
Oct 15, 2026
Johnson Tim Donald
Chief Executive Officer
TAX W/H$75.4K
Oct 15, 2026
Hasan Zain Syed
Chief Growth Officer
TAX W/H$4.3K
Oct 7, 2026
Howard William D.
Director
AWARD$20.0K

Earnings setup

Estimates
Nov 16
reports in 21 days
−$0.04
EPS estimate, this quarter
−238%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.04-$0.06–-$0.03-28.6%$6.4M
Next Q-$0.07-$0.11–-$0.02-160.0%$8.5M
Current FY-$0.16-$0.20–-$0.12-45.5%$31.8M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
408,599
shares short
-33.5%
vs prior settlement
1.0
days to cover
≈0.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Sanjay Shrestha, CEO of Health In Tech, Inc., filed a Form 3 initial statement of beneficial ownership, disclosing…
3 — Impact 2/10
Oct 20, 2026 Listing status
Listing Status: HIT — Deficient (was Normal)
Health In Tech, Inc. - Class A Common Stock | Nasdaq Financial Status Indicator N → D
Oct 20, 2026 Insider
Shrestha Sanjay K was granted 2,000,000 shares
Chief Executive Officer
Oct 20, 2026 Insider
Shrestha Sanjay K was granted 1,500,000 shares
Chief Executive Officer
Oct 20, 2026 Insider
Shrestha Sanjay K was granted 500,000 shares
Chief Executive Officer
Oct 16, 2026 SEC
Health In Tech received two Nasdaq deficiency notices: (1) failure to comply with independent director and audit…
8-K — Impact 8/10
Oct 16, 2026 SEC
The SEC declared effective Health In Tech's S-3 registration statement (File No. 333-298758) on October 15, 2026. This…
EFFECT — Impact 6/10
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — DOUBLED
176,911 shares ($178.7K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 16, 2026
Earnings date
HIT Q3 2026 Earnings Scheduled — 2026-11-16
Recent
Oct 20, 2026
Listing
Listing Status: HIT — Deficient (was Normal)
Health In Tech, Inc. - Class A Common Stock | Nasdaq Financial Status Indicator N → D
Oct 16, 2026
Company news
Health In Tech to Host Annual Meeting of Stockholders
STUART, Fla., Oct. 16, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") will host its 2026 Annual Meeting…
Oct 2, 2026
Press release
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the…
Sep 30, 2026
Earnings
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment…
Sep 15, 2026
Short interest
Short Interest: HIT up 40% to 0.6M shares
Settlement 2026-09-15 | Days to cover: 10.55 | ≈0.94% of shares outstanding (est.)

SecBot reports

14 filings · 0 bullish · 10 bearish · 1 mixed · 3 neutral
All HIT filing & press-release reports (14)